---
id: CVE-2025-52653
title: >-
  HCL MyXalytics product is affected by Cross Site Scripting vulnerability in
  the web application
summary: >-
  HCL MyXalytics product is affected by Cross Site Scripting vulnerability in
  the web application. This can allow the execution of unauthorized scripts,
  potentially resulting in unauthorized actions or access.
severity: high
cvss: 7.6
cvssVector: 'CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H'
cwe:
  - CWE-79
vendor: hcltech
product: dryice_myxalytics
affected:
  - dryice_myxalytics = 6.6
published: '2025-10-03'
updated: '2026-09-30'
sourceUpdated: '2026-09-30T23:10:00.237'
source: NVD
sourceUrl: 'https://nvd.nist.gov/vuln/detail/CVE-2025-52653'
references:
  - url: >-
      https://support.hcl-software.com/csm?id=kb_article&sysparm_article=KB0124411
    label: psirt@hcl.com
tags:
  - nvd
epss: 0.00259
epssPercentile: 0.15935
ingestedAt: '2026-09-30T23:29:32.415Z'
---

## Overview

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

## Affected

- `dryice_myxalytics = 6.6`

## Remediation

Refer to the linked advisories for vendor-supplied fixes and affected version ranges.